XOMA Corp (XOMA)
25.21
-0.23
(-0.90%)
USD |
NASDAQ |
May 03, 16:00
25.21
0.00 (0.00%)
After-Hours: 19:19
XOMA Free Cash Flow: -18.16M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -18.16M |
| September 30, 2023 | -18.12M |
| June 30, 2023 | -19.68M |
| March 31, 2023 | -16.79M |
| December 31, 2022 | -12.88M |
| September 30, 2022 | 21.65M |
| June 30, 2022 | 22.24M |
| March 31, 2022 | 22.58M |
| December 31, 2021 | -3.822M |
| September 30, 2021 | -11.99M |
| June 30, 2021 | -4.356M |
| March 31, 2021 | -3.251M |
| December 31, 2020 | 8.883M |
| September 30, 2020 | -11.74M |
| June 30, 2020 | -18.50M |
| March 31, 2020 | -24.72M |
| December 31, 2019 | -19.58M |
| September 30, 2019 | -18.15M |
| June 30, 2019 | -26.70M |
| March 31, 2019 | -20.95M |
| December 31, 2018 | -27.65M |
| September 30, 2018 | -30.15M |
| June 30, 2018 | 18.24M |
| March 31, 2018 | 13.19M |
| December 31, 2017 | 2.678M |
| Date | Value |
|---|---|
| September 30, 2017 | 14.86M |
| June 30, 2017 | -27.83M |
| March 31, 2017 | -31.78M |
| December 31, 2016 | -33.75M |
| September 30, 2016 | -11.92M |
| June 30, 2016 | -18.96M |
| March 31, 2016 | -23.13M |
| December 31, 2015 | -31.32M |
| September 30, 2015 | -77.60M |
| June 30, 2015 | -74.46M |
| March 31, 2015 | -74.86M |
| December 31, 2014 | -78.61M |
| September 30, 2014 | -68.54M |
| June 30, 2014 | -65.63M |
| March 31, 2014 | -60.31M |
| December 31, 2013 | -47.08M |
| September 30, 2013 | -51.42M |
| June 30, 2013 | -50.52M |
| March 31, 2013 | -46.08M |
| December 31, 2012 | -43.27M |
| September 30, 2012 | -40.33M |
| June 30, 2012 | -36.17M |
| March 31, 2012 | -40.50M |
| December 31, 2011 | -32.37M |
| September 30, 2011 | -33.25M |
Free Cash Flow Range, Past 5 Years
-26.70M
Minimum
Jun 2019
22.58M
Maximum
Mar 2022
-8.057M
Average
-12.88M
Median
Dec 2022
Free Cash Flow Benchmarks
| Kinnate Biopharma Inc (DELISTED) | -100.04M |
| Societal CDMO Inc (DELISTED) | -9.242M |
| Corcept Therapeutics Inc | 126.90M |
| Sarepta Therapeutics Inc | -653.88M |
| AnaptysBio Inc | -121.61M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.927M |
| Cash from Investing (Quarterly) | 5.511M |
| Cash from Financing (Quarterly) | 124.49M |
| Free Cash Flow Per Share (Quarterly) | -0.3419 |
| Free Cash Flow to Equity (Quarterly) | -127.99M |
| Free Cash Flow Yield | -6.28% |